These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9244966)

  • 21. Indinavir and thrombocytopenia.
    Durand JM
    AIDS; 1999 Jan; 13(1):148-9. PubMed ID: 10207566
    [No Abstract]   [Full Text] [Related]  

  • 22. Nephropathy and renal colic in patients treated with indinavir, ritonavir plus indinavir or ritonavir plus saquinavir.
    Padberg J; Fritsche L; Bergmann F; Schürmann D; Suttorp N
    AIDS; 1999 Oct; 13(15):2173-4. PubMed ID: 10546875
    [No Abstract]   [Full Text] [Related]  

  • 23. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
    Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Nerad JL; Kessler HA
    Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
    Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
    AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diabetes mellitus in HIV therapy].
    Hänsel A
    Praxis (Bern 1994); 2000 Dec; 89(49):2081-2. PubMed ID: 11190851
    [No Abstract]   [Full Text] [Related]  

  • 28. Persistent nephrolithiasis after discontinuation of indinavir therapy.
    Polhemus ME; Aronson NE
    Clin Infect Dis; 1998 Dec; 27(6):1536-7. PubMed ID: 9868678
    [No Abstract]   [Full Text] [Related]  

  • 29. [A plea for an individualized therapy regimen. Which is the optimal dose?].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():26-7. PubMed ID: 12043067
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors.
    Pollmann H; Richter H; Jürgens H
    Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
    Duval X; Journot V; Leport C; Chêne G; Dupon M; Cuzin L; May T; Morlat P; Waldner A; Salamon R; Raffi F;
    Clin Infect Dis; 2004 Jul; 39(2):248-55. PubMed ID: 15307035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].
    Altinbaş A; Ozkaya G; Büyükaşik Y; Unal S
    Mikrobiyol Bul; 2007 Jul; 41(3):473-6. PubMed ID: 17933262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients.
    Quirino T; Niero F; Ricci E; Pusterla L; Carradori S; Gabbuti A; Iemoli E; Landonio S; Faggion I; Bonfanti P;
    Antivir Ther; 2000 Sep; 5(3):195-7. PubMed ID: 11075939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Large, atypical accumumlation of adipose tissue in a patient with human immunodeficiency virus infection].
    García de la Llana F; Morales F
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):431-2. PubMed ID: 9887631
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir.
    Gisslén M; Norkrans G; Svennerholm B; Hagberg L
    AIDS; 1998 Jan; 12(1):114-6. PubMed ID: 9456264
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the combination of hepatitis and indinavir potentially dangerous?
    Jeurissen FJ; Schneider MM; Borleffs JC
    AIDS; 1998 Mar; 12(4):441-2. PubMed ID: 9520177
    [No Abstract]   [Full Text] [Related]  

  • 38. Indinavir-associated hepatitis in patients with advanced HIV infection.
    Vergis E; Paterson DL; Singh N
    Int J STD AIDS; 1998 Jan; 9(1):53. PubMed ID: 9518018
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal tolerance of indinavir in HIV-positive patients.
    Guery B; Tubiana R; Martinez F; Jacquiaud C; Bochet M; Katlama C; Deray G
    Nephron; 1999; 82(1):72. PubMed ID: 10224487
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute monoarthritis complicating therapy with indinavir.
    Brooks JI; Gallicano K; Garber G; Angel JB
    AIDS; 2000 Sep; 14(13):2064-5. PubMed ID: 10997421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.